RESEARCH VIA NIFTY REPORT 25 JAN 2014

ECONOMY ANALYSIS

 USFDA bans Ranbaxy's Toansa API plant, finds cGMP violation
 Sonia Gandhi's office refers traders demand to Anand Sharma
 Market sees Rajan holding rates on Tuesday: RBS survey
 India story intact, investors reposing confidence: Sharma
 Sensex, Nifty weak; Ranbaxy falls 20% post USFDA ban
 Wall St falls as China data trigger selloff in risky assets
 RBI aligns NBFC loan restructuring norms with banks.

MARKET ANALYSIS

 The S&P BSE Midcap Index fell 1.66 per cent and the S&P BSE Smallcap Index was down 1.81 per cent.
 The markets corrected sharply on the last trading day of the week on the back of weakness in global markets. Selling pressure was seen in rate sensitive sectors as as weak hands chose to remain on sidelines ahead of the Reserve Bank of India's policy review meet.

 "Markets were largely ranged during the week as specific stocks reacted to results. There was no major economic data domestically. However, on Friday markets did react to the weak economic data in China and US. Most of the results which have come are in line with our expectations with no major
deviations in most stocks," said Dipen Shah, Head- Private Client Group Research, Kotak Securities.

 The 30-share index ended at 21,133.56, down 240.10 points or 1.12 per cent. It touched a high of 21,333.66 and a low of 21,123.99 in trade today.

 The Nifty closed at 6,268.65, down 77 points or 1.21 per cent. It touched a high of 6,331.45 and a low of 6,263.90 in trade today. 

0 comments:

Post a Comment